Our staff will work with you on your weight loss journey, offering the support and respect you deserve
Evidence and Guidance Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide and liraglutide, are increasingly prescribed for type 2 diabetes and weight management in the UK
Designed for accuracy and ease of use, our solutions support reliable decision-making in research and clinical settings
Contact your GP or healthcare provider if you notice: Gradual reduction in hearing ability in one or both ears Persistent ringing, buzzing, or other noises in the ears (tinnitus) Difficulty understanding speech, particularly in noisy environments A sensation of fullness or pressure in the ears Dizziness or balance problems accompanying hearing changes Seek urgent same-day medical attention if you experience: Sudden hearing loss developing over 72 hours or less this is considered an ENT emergency requiring same-day specialist assessment
These standards guarantee research grade consistency and reliability across all product batches for reproducible results in various research settings
It further suggests that disruption of hypothalamic pathways involved in appetite and energy homeostasis may result in alterations in other pathways such as GLP-1-mediated signaling in the brainstem, which remain intact in HO patients
